Next Article in Journal
Nasal Planum Vasculopathy in a Scottish Terrier Dog Treated with Ciclosporin and Endonasal Stents
Next Article in Special Issue
The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients
Previous Article in Journal
Novel Flu Viruses in Bats and Cattle: “Pushing the Envelope” of Influenza Infection
Previous Article in Special Issue
Combination of Suicide and Cytokine Gene Therapies as Surgery Adjuvant for Canine Mammary Carcinoma
 
 
Article

CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma

1
Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE C1A 4P3, Canada
2
Diagnostic Services, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PE C1A 4P3, Canada
3
Department of Veterinary Biomedical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA
4
Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA
*
Author to whom correspondence should be addressed.
Vet. Sci. 2018, 5(3), 72; https://doi.org/10.3390/vetsci5030072
Received: 16 July 2018 / Revised: 2 August 2018 / Accepted: 9 August 2018 / Published: 13 August 2018
(This article belongs to the Special Issue Canine Cancer Immunotherapeutics)
Feline oral squamous cell carcinoma (OSCC) is a highly invasive form of cancer in cats. In human OSCC, cluster of differentiation 147 (CD147) contributes to inflammation and tumor invasiveness. CD147 is a potential therapeutic target, but the expression of CD147 in feline OSCC has not been examined. Immunohistochemistry was used to determine if cyclooxygenase 2 (COX-2) and CD147 expression in feline OSCC biopsies was coordinated. Tumor cells were more likely to express COX-2 (22/43 cases or 51%) compared to stroma (8/43 or 19%) and adjacent oral epithelium (9/31 cases or 29%) (p < 0.05). CD147 was also more likely to occur in tumor cells compared to stroma and adjacent mucosa, with 21/43 (49%) of cases having >50% tumor cells with mild or moderate CD147 expression, compared to 9/28 (32%) in adjacent epithelium and only 5/43 (12%) in adjacent stroma (p < 0.05). In feline OSCC cell lines (SCCF1, SCCF2, and SCCF3), CD147 gene expression was more consistently expressed compared to COX-2, which was 60-fold higher in SCCF2 cells compared to SCCF1 cells (p < 0.05). CD147 expression did not correlate with COX-2 expression and prostaglandin E2 (PGE2) secretion, indicating that they may be independently regulated. CD147 potentially represents a novel therapeutic target for the treatment of feline OSCC and further study of CD147 is warranted. View Full-Text
Keywords: feline; oral squamous cell carcinoma; CD147; EMMPRIN; Basigin; COX-1; COX-2; PGE2; inflammation; invasion feline; oral squamous cell carcinoma; CD147; EMMPRIN; Basigin; COX-1; COX-2; PGE2; inflammation; invasion
Show Figures

Figure 1

MDPI and ACS Style

Nasry, W.H.S.; Wang, H.; Jones, K.; Dirksen, W.P.; Rosol, T.J.; Rodriguez-Lecompte, J.C.; Martin, C.K. CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma. Vet. Sci. 2018, 5, 72. https://doi.org/10.3390/vetsci5030072

AMA Style

Nasry WHS, Wang H, Jones K, Dirksen WP, Rosol TJ, Rodriguez-Lecompte JC, Martin CK. CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma. Veterinary Sciences. 2018; 5(3):72. https://doi.org/10.3390/vetsci5030072

Chicago/Turabian Style

Nasry, Walaa Hamed Shaker, Haili Wang, Kathleen Jones, Wessel P. Dirksen, Thomas J. Rosol, Juan Carlos Rodriguez-Lecompte, and Chelsea K. Martin. 2018. "CD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma" Veterinary Sciences 5, no. 3: 72. https://doi.org/10.3390/vetsci5030072

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop